The Norwegian Institute of Public Health (FHI) will assess whether the AstraZeneca vaccine should be part of Norway’s vaccination program.
The FHI’s chief Camilla Stoltenberg announced the information at Wednesday’s press conference on the corona situation.
“Regardless of what the European Medicines Agency (EMA) and the Norwegian Medicines Agency come to, the National Institute of Public Health, which is responsible for the national corona vaccination program, will make an independent assessment of whether we will continue to offer this vaccine in the (vaccination) program in Norway,” Stoltenberg said.
Stoltenberg also said that it is important that Norwegian maintain confidence in the vaccination program and vaccines in the time ahead.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at email@example.com